Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system

Lung Cancer. 2017 Apr:106:83-92. doi: 10.1016/j.lungcan.2017.01.017. Epub 2017 Jan 30.

Abstract

The development of new immune treatment in oncology and particularly for lung cancer may induce new complications, particularly activation or reactivation of auto-immune diseases. In this context, a systematic review on the auto-immune paraneoplastic syndromes that can complicate lung cancer appears useful. This article is the third of a series of five and deals mainly with neurological paraneoplastic syndromes involving the central nervous system.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • England
  • Female
  • Humans
  • Immunotherapy / adverse effects*
  • Lung Neoplasms / complications*
  • Lung Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Nervous System Autoimmune Disease, Experimental / chemically induced*
  • Paraneoplastic Syndromes, Nervous System / chemically induced
  • Paraneoplastic Syndromes, Nervous System / immunology*
  • Paraneoplastic Syndromes, Nervous System / pathology
  • Prospective Studies
  • Small Cell Lung Carcinoma / complications*
  • Small Cell Lung Carcinoma / drug therapy